NCT07748208
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07748208
Title A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
MedStar Washington Hosp Center RECRUITING Washington D.C. District of Columbia 20010 United States Details
Grady Memorial Hospital RECRUITING Atlanta Georgia 30303-3031 United States Details
Emory University Hospital Midtown RECRUITING Atlanta Georgia 30308-2212 United States Details
Emory University Hospital RECRUITING Atlanta Georgia 30322 United States Details
Nebraska Cancer Specialists St Francis - Grand Island RECRUITING Grand Island Nebraska 68803 United States Details
Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68114 United States Details
NYU Langone Hospital Long Island Clinical Research RECRUITING Mineola New York 11501-4089 United States Details
NYU Langone?s Perlmutter Cancer Center - 160 E 34th St RECRUITING New York New York 10016-4744 United States Details
West Virginia University RECRUITING Morgantown West Virginia 26506-1200 United States Details
Pan American Center for Oncology Trials, LLC RECRUITING Dorado 00646-2202 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field